Literature DB >> 6216907

Inhibition of neutrophil migration by etretinate and its main metabolite.

L Dubertret, C Lebreton, R Touraine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216907     DOI: 10.1111/j.1365-2133.1982.tb00528.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  15 in total

1.  The influence of retinoic acid and retinoic acid derivatives on beta2 integrins and L-selectin expression in HL-60 cells in vitro.

Authors:  F Sjögren; O Stendahl; O Ljunghusen
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

2.  Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes.

Authors:  R Fumarulo; M Conese; S Riccardi; D Giordano; P Montemurro; M Colucci; N Semeraro
Journal:  Agents Actions       Date:  1991-11

Review 3.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

4.  The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.

Authors:  E Wong; R M Barr; S D Brain; M W Greaves; L A Olins; A I Mallet
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 5.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

Review 6.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

7.  The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.

Authors:  G Wozel; A Chang; M Zultak; B M Czarnetzki; R Happle; J Barth; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 8.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

9.  Synthetic retinoids inhibit histamine release from isolated human mast cells.

Authors:  D Eichelberg; W Schmutzler
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

10.  Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.

Authors:  R E Schopf; J Höcher; M Rehder; L Färber; B Morsches
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.